Study Funded by ADA Shows CDEs in Primary Care Improve Health of T2DM Patients
Patients in practices where certified diabetes educators were embedded in practices were more likely to have medication adjusted quickly, with better health outcomes.
Family-Focused Intervention Produces Positive Health Outcomes for African Americans With T2DM
Natasha Greene, PhD, FNP, BC, found that educating a family member alongside the person with type 2 diabetes mellitus produced better health outcomes than traditional education.
Links Found Among Higher Co-Payments, Lower Adherence, Higher Medical Costs in T2DM Medicare Patients
The study presented at the ADA Scientific Sessions found that raising out-of-pocket costs for diabetics with Medicare could reduce adherence and ultimately raise healthcare spending.
Review of Amgen Cholesterol Drug Favored by FDA Panel
An overview of mechanism of action, dosing, interactions, and precautions for evolocumab, which faces an FDA deadline for review August 27, 2015.
Session on Population Management Highlights Shift Toward Value-Based Models in Diabetes Care
The shift in care for those with diabetes is about new payment models and a change in mindset, said the speakers, including Robert A. Gabbay, MD, PhD, of Joslin Diabetes Center.
ITCA 650 Results Point to "Transformational" Method to Deal With Poor Adherence in T2DM
A matchstick-like device provides continuous delivery of exenatide, producing dramatic reductions in A1C levels.
Medtronic Makes News at ADA With 640G Results, Samsung Partnership, Start of Pivotal Trial
The sessions offered a backgroup to announced new partnerships and reveal new technology.
NEJM Study: Aflibercept Offers Benefits Over Rivals for DME if Vision Loss Is Worse at Outset
The study evaluated the 3 new anti-VEGF agents for treatment of a condition that frequently occurs in patients who suffer from diabetes mellitus.
FDA Approves Software Update for Dexcom Pediatric CGM System
Caution in PCSK9 Inhibitor Votes Reflects Sentiment of Earlier Reviews
A review published before FDA's vote on alirocumab outlines how editorials in 2 major journals were reflected in subsequent votes by advisory panels.
Sanofi Addresses Need for Spirometry Before Physicians Can Prescribe Afrezza
The need for spirometry before physicians can write an Afrezza prescription has been cited by analysts as an impediment to broader use of the inhaled insulin.
How Digital Therapeutics Can Help Payers Comply With Upcoming Government Guidance-and Deliver Outcomes
The CDC has found that some digital programs meet standards required to help payers deliver behavioral health programs for persons with obesity, or those who are overweight with at least 1 cardiovascular risk factor.
Can mHealth Revolutionize Evidence-Based Practice in Diabetes Care?
Data from mHealth can inform, assess, anticipate, and aid in interventions while monitoring and coordinating patient health status and care.
On Lessons Learned: Express Scripts' Steve Miller, MD, Discusses HCV Experience, PCSK9 Inhibitors, and More
On the eve of FDA's deadline for acting on the first of an expensive new class of cholesterol therapies, the chief medical officer of the nation's largest pharmacy benefit manager weighs on what steps it is taking on behalf of customers in this changing landscape.
Medicare's Failure to Cover CGM at Odds With Other Health, Research Agencies
A leading voice on diabetes care asks why Medicare still will not cover CGM technology.
Multiple Teams Move to Testing Phase of the Artificial Pancreas
Years of work has moved technology to the point of large-scale testing that is required before FDA approval and commercialization.
2 Clarke Drive Cranbury, NJ 08512